Hypera S.A. (HYPE3.SA)

30,26 +0,47 (+1,58%) Alla chiusura: 05:07PM BRT

Hypera S.A.

Av. Magalhães de Castro, 4800
240 Floor Continental Tower Building Bairro Cidade Jardim
São Paulo, SP 05676-120
Brazil
55 11 3627 4206
https://www.hyperapharma.com.br

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 10.301

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Breno Toledo Pires de Oliveira	CEO & Director	N/D	N/D	N/D
Mr. Adalmario Ghovatto Satheler do Couto	Investor Relations Officer & CFO	N/D	N/D	N/D
Mr. Carlos Roberto Scorsi	Chief Operating officer	N/D	N/D	1962
Juliana Aguinaga Damião Salem	Senior Legal Officer & Director	N/D	N/D	N/D
Joao Felipe Khamis Aguilar	Risks & Compliance Officer	N/D	N/D	N/D
Mr. Luiz Eduardo Sales Clavis	VP of Sales and Marketing & Director	N/D	N/D	N/D
Mauricio Christovam	Senior Human Resources Officer	N/D	N/D	N/D
Mr. Hélio Segouras	Head of Consumer Health	N/D	N/D	N/D

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in BRL.

Descrizione

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, balance, Flavonid, histamin, NeoFresh, neolefrin, Neochemistry Vitamins, Neosorum, and Torsilax brand names; and consumer health products under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

Governance aziendale

L'ISS Governance QualityScore di Hypera S.A. al 1 maggio 2024 è 6. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 7; diritti degli azionisti: 1; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.